19-53050162-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001191055.2(ERVV-2):c.911G>A(p.Arg304Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000723 in 1,441,736 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001191055.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERVV-2 | NM_001191055.2 | c.911G>A | p.Arg304Gln | missense_variant | 2/2 | ENST00000601417.3 | NP_001177984.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERVV-2 | ENST00000601417.3 | c.911G>A | p.Arg304Gln | missense_variant | 2/2 | 4 | NM_001191055.2 | ENSP00000472919.1 |
Frequencies
GnomAD3 genomes AF: 0.000367 AC: 54AN: 146966Hom.: 1 Cov.: 22
GnomAD3 exomes AF: 0.000303 AC: 35AN: 115562Hom.: 0 AF XY: 0.000302 AC XY: 19AN XY: 62826
GnomAD4 exome AF: 0.000764 AC: 989AN: 1294770Hom.: 26 Cov.: 29 AF XY: 0.000692 AC XY: 444AN XY: 641732
GnomAD4 genome AF: 0.000367 AC: 54AN: 146966Hom.: 1 Cov.: 22 AF XY: 0.000294 AC XY: 21AN XY: 71380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.911G>A (p.R304Q) alteration is located in exon 2 (coding exon 1) of the ERVV-2 gene. This alteration results from a G to A substitution at nucleotide position 911, causing the arginine (R) at amino acid position 304 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at